764148 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
528 Correlation of baseline circulating Vg9Vd2 T cell counts and pharmacodynamic activity of ICT01 in cancer patients: preliminary results from EVICTION and a novel patient enrichment strategy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.528 |
Valentin Emmanuel, Gassart Aude de, Brune Patrick, Ghigo Clément, Agaugué Sophie, Olive Daniel, Frohna Paul |
764147 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
527 Digital spatial profiling of paired tumor biopsies reveals indoleamine 2,3-dioxygenase (IDO)1 as a potential resistance mechanism for a tumor-targeted 4–1BB agonist in patients with solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.527 |
Tanos Tamara, Heichinger Christian, Wilson Sabine, Canamero Marta, Bustamante Mariana, Ooi Chiahuey, Klaman Irina, Gomes Bruno, Ceppi Maurizio, Ceppi Maurizio |
764146 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis |
2021-11-01 |
10.1136/jitc-2021-sitc2021.526 |
Tamir Ayala, Harati Hagit, Asher Nethanel, Stoff Ronen, Grynberg Shirly, Segal Robert, Ostrowski Adam, Florin Lawrence, Shapira-Frommer Ronnie, Markel Gal |
764145 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
931 LncRNA Malat1 regulated Serpinb6b signaling suppresses pyroptosis and governs breast cancer dormancy reactivation and through immune evasion |
2021-11-01 |
10.1136/jitc-2021-sitc2021.931 |
Kumar Dhiraj, Giancotti Filippo |
764144 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
930 Fibroblast activation protein alpha expression in tumor stroma and its association with immuno-regulatory circuits across epithelial tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.930 |
Kraxner Anton, Braun Franziska, Cheng Wei-Yi, Canamero Marta, Andersson Emilia, Harring Suzana Vega, Dziadek Sebastian, Broeske Ann-Marie, Ceppi Maurizio, Teichgraeber Volker, Charo Jehad |
764143 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
929 Dissecting intratumoral immune organization: defining the comparative cellular composition of tertiary lymphoid structures T-cell supportive antigen presenting niches in renal tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.929 |
Jansen Caroline, Sobierajska Ewelina, Greenwald Rachel, Carlisle Jennifer, Mullane Patrick, Prokhnevska Nataliya, Cardenas Maria, Bilen Mehmet, Osunkoya Adeboye, Master Viraj, Kissick Haydn |
764142 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
928 A translational approach to catalog pancreatic cancer heterogeneity using spatial genomics in large patient cohorts for target validation and rational combination selection |
2021-11-01 |
10.1136/jitc-2021-sitc2021.928 |
Jabado Omar, Fan Li, Souza Patricia Coutinho de, Harris Angelo, Chaparro Arturo, Qutaish Mohammed, Si Han, Dannenberg Jan-Hermen, Sasser Kate, Couto Suzana, Fereshteh Mark |
764141 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
927 Wilms tumor reveals DNA repair gene hyper-expression is linked to lack of immune infiltration |
2021-11-01 |
10.1136/jitc-2021-sitc2021.927 |
Higgs Emily, Bao Riyue, Hatogai Ken, Gajewski Thomas |
764140 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
926 Immune profiling of KEAP1-deficient NSCLC: development of therapeutic strategies to overcome resistance to immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.926 |
Galan-Cobo Ana, Qian Yu, Peng Fuduan, McGrail Daniel, Zhang Fahao, Zhang Xiang, Parra Edwin, Dang Minghao, Rodriguez Saxon, Reuben Alexandre, Wistuba Ignacio, Skoulidis Ferdinandos, Wang Linghua, Heymach John |
764139 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
925 Utilizing multiplex immunofluorescence to explore the epithelial-mesenchymal transition in breast, ovarian cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.925 |
Fails Danielle, Spencer Michael |